Patoulias, D.; Papadopoulos, C.; Zografou, I.; Katsimardou, A.; Karagiannis, A.; Doumas, M.
Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study. Medicina 2022, 58, 1167.
https://doi.org/10.3390/medicina58091167
AMA Style
Patoulias D, Papadopoulos C, Zografou I, Katsimardou A, Karagiannis A, Doumas M.
Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study. Medicina. 2022; 58(9):1167.
https://doi.org/10.3390/medicina58091167
Chicago/Turabian Style
Patoulias, Dimitrios, Christodoulos Papadopoulos, Ioanna Zografou, Alexandra Katsimardou, Asterios Karagiannis, and Michael Doumas.
2022. "Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study" Medicina 58, no. 9: 1167.
https://doi.org/10.3390/medicina58091167
APA Style
Patoulias, D., Papadopoulos, C., Zografou, I., Katsimardou, A., Karagiannis, A., & Doumas, M.
(2022). Effect of Empagliflozin and Dapagliflozin on Ambulatory Arterial Stiffness in Patients with Type 2 Diabetes Mellitus and Cardiovascular Co-Morbidities: A Prospective, Observational Study. Medicina, 58(9), 1167.
https://doi.org/10.3390/medicina58091167